基于早期适时风险评估的分级个性化防控护理在慢性阻塞性肺疾病患者静脉血栓栓塞症预防中的应用

Application of graded personalized prevention and control nursing based on timely risk assessment during early stage in venous thromboembolism prevention of patients with chronic obstructive pulmonary disease

目的探讨基于早期适时风险评估的分级个性化防控护理在慢性阻塞性肺疾病患者静脉血栓栓塞症(VTE)预防中的应用效果。方法将基于早期适时风险评估的分级个性化防控护理实施前(2017年6—12月)和实施后(2018年1—6月)入住我院治疗的慢性阻塞性肺疾病患者各150例纳为研究样本,将实施前后患者分别设置为对照组和试验组,对照组接受常规VTE预防护理,试验组接受基于早期适时风险评估的分级个性化防控护理,比较两组患者干预后VTE发生情况及护理满意度。结果试验组患者干预后VTE发生率显著低于对照组(P <0. 05),试验组干预后各项护理满意度评分均显著高于对照组(P <0. 05)。结论采用基于早期适时风险评估的分级个性化防控护理对慢性阻塞性肺疾病患者开展VTE预防活动,可显著降低VTE发生率,深受慢性阻塞性肺疾病患者认可。

Objective To explore the application effect of graded personalized prevention and control nursing based on timely risk assessment during early stage in venous thromboembolism(VTE) prevention of patients with chronic obstructive pulmonary disease. Methods To select two groups of 150 patients with chronic obstructive pulmonary disease who were admitted to our hospital before the implementation of graded personalized prevention and control nursing based on early timely risk assessment (from June 2017 to December 2017) and after implementation (from January 2018 to June 2018) as the study samples. These study samples were set as the control group and the study group before and after the implementation of the nursing. The control group was given routine VTE preventive care, while the study group was given graded personalized prevention and control nursing based on early timely risk assessment. The VTE occurrence and nursing satisfaction of patients after intervention in the two groups were compared. Results After the intervention, the incidence of VTE in the study group was significantly lower than that in the control group( P <0.05). After the intervention, the nursing satisfaction scores of the study group were significantly higher than those in the control group( P <0.05). Conclusion Applying graded personalized prevention and control nursing based on early timely risk assessment for VTE prevention activities in patients with chronic obstructive pulmonary disease can reduce the incidence of VTE significantly. Therefore, it is highly recognized by patients with chronic obstructive pulmonary disease.